CIK 0002022416
- Emerging growth company
Silexion Therapeutics Corp
Sign in to watch- Ticker
- SLXN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- Phone
- +972 86286005
- Business address
- 12 ABBA HILLEL ROAD, RAMAT GAN, Israel, 5250606
- Former names
- Biomotion Sciences
Securities
- SLXN Ordinary Shares Nasdaq
- SLXNW Warrant Nasdaq
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- S-4 Deal Registration Statement - Business Combination
Page 5 of 5 · 93 filings